Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Jubilant Pharmova Limited ( (IN:JUBLPHARMA) ) is now available.
Jubilant Pharmova Limited announced its unaudited financial results for the quarter and half-year ended September 30, 2025. The results, approved by the Board of Directors, were prepared in compliance with Indian Accounting Standards and SEBI regulations. The review by independent auditors concluded that the financial statements were presented fairly without any material misstatements, indicating stable financial management and compliance with regulatory standards.
More about Jubilant Pharmova Limited
Jubilant Pharmova Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of a wide range of pharmaceutical products. The company is engaged in providing solutions across the pharmaceutical value chain, including active pharmaceutical ingredients, generics, and specialty pharmaceuticals, catering to a global market.
Average Trading Volume: 8,283
Technical Sentiment Signal: Buy
Current Market Cap: 178.3B INR
For an in-depth examination of JUBLPHARMA stock, go to TipRanks’ Overview page.